SSCS-Personal-Peptides-Speeds-Genomic-Analytics-with-Optimized-AWS-Infrastructure

Profile

 

Founded in Houston, Texas, Personal Peptides is the first company to develop a nutrigenomic tool for cancer patients, designed to improve their cancer specific immune system. By bridging the gap between the human immune system and personal genomics, Personal Peptides aims to provide individuals with the tools to sculpt their own immune repertoires.  

Challenges

 

  • Personal Peptides needed commercial, high performance solutions to process big data at massive scale. 

  • Meeting HIPAA requirements and enabling Personal Peptides to control and protect client information along the supply chain was essential.

  • Maintaining competitive advantage through efficient use of computing resources was imperative in the competitive field of biometrics.

  • Managing hardware would not be a viable option; the company needs to remain agile, manage periodic spikes in demand and rely on a self-managing infrastructure.

 

Solution

Download the case study using the form at the right to continue reading the full case study, including how Flux7 provided a high performance, scalable infrastructure.

 

Why Flux7?

Enterprises gain fast time to value from Flux7 cloud implementation, automation and DevOps consulting services and solutions. Bring ideas to life and shorten time to market with modern IT systems and workflows that scale, secure and increase the efficiency of technology service delivery. Flux7 Premier AWS Consulting Partners provide insight and expertise from 300+ DevOps projects.

 

 

 

 

 

 

Download the Personal Peptides Case Study: